In the same network (Figure 3), IL-1β interacts with ADRB2; hence, recent findings highlight mechanisms through which the hypoxic tumor microenvironment may contribute to BC progression and suggest additional therapeutic targets. This evidence concerns the gene ADRB2 and neoplasm.